Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide. For most intermediate-advanced HCC patients, transarterial embolization (TAE) therapy is the ...
“[...] this study proposed that the size of the tumor [...] and lipiodol washout rate could predict the outcome of cTACE in patients with metastatic liver tumors ...
Which is more recommendable as the second line chemotherapy to S-1 for advanced gastric cancer; combination of CPT-11 plus CDDP or weekly paclitaxel? No significant financial relationships to disclose ...
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer-related mortality across the globe. Transarterial embolization (TAE) therapy is the standard of care for most patients ...
Injection of lipiodol in a kidney. Injection of lipiodol in a kidney.
Guerbet LLC, USA-- Guerbet, a pioneer in the field of contrast agents with more than 80 years of experience, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug ...
VILLEPINTE, France, April 24, 2026 /PRNewswire/ --GUERBET (FR0000032526 GBT): Guerbet, a global leader in medical imaging, announces a positive outcome from a worksharing procedure, involving several ...
From the Thoracic Clinic of the Beth Israel Hospital. Henry L. Cabitt, M.D. Assistant in surgery, Tufts College Medical School; surgeon to the Thoracic Clinic, Beth Israel Hospital. Alfred Hurwitz, ...
A schematic diagram showing the preparation of a pH-responsive Lipiodol Pickering emulsion-based microreactor for transarterial ferro-embolization therapy of HCC. Nowadays, hepatocellular carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results